Stephen Parker

Stephen Parker

Chairman chez BIODEXA PHARMACEUTICALS PLC

Fortune : 15 774 $ au 31/03/2024

65 ans
Health Technology
Finance
Commercial Services

Profil

Stephen B.
Parker
is the founder of UK Stem Cell Foundation.
He currently holds multiple positions, including Non-Executive Chairman at Sareum Holdings Plc, Biodexa Pharmaceuticals Plc, and Drishti Discoveries Ltd.
He is also a Director at Sareum Ltd., Sp2 Consulting Ltd., Eternans Ltd., and Sp2 Asset Management Ltd.
In addition, he is a Partner at Celtic Pharma Management LP.
In his former roles, Dr. Parker served as Non-Executive Chairman at Argent BioPharma Ltd.
and Physiomics Plc.
He was also Chairman at Ah Animal Healthcare Ltd.
and Liverpool Chirochem Ltd.
Furthermore, he held positions as a Director at Xenova Group Plc, Silence Therapeutics Plc, GCA Altium Ltd., Celtic Pharma Development UK Plc, Novacta Biosystems Ltd., PBB Devices Ltd., Xenova Ltd., and Gammadelta Therapeutics Ltd.
He worked as a Principal at Apax Partners LLP, Celtic Pharma Holdings Advisors LLP, Pa Consulting Group Ltd., and Warburg Group Plc.
Additionally, he served as Chief Financial Officer at Oxford GlycoSciences Plc and was a Principal at Barings Plc.
He was also a Partner at Beehive Capital LLP and held the position of Head-Partner Network, Research & Development at Bedford Royalties Ltd.Dr. Parker's education includes a doctorate from the University of Oxford, an undergraduate degree from the University of East Anglia, and an MBA from Bayes Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
28/03/2024 116 158 ( 0,16% ) 15 774 $ 31/03/2024

Postes actifs de Stephen Parker

SociétésPosteDébut
SAREUM HOLDINGS PLC Chairman 17/05/2016
BIODEXA PHARMACEUTICALS PLC Chairman 20/06/2022
Director/Board Member -
Chairman 01/01/2021
Eternans Ltd. Director/Board Member -
Sp2 Consulting Ltd. Director/Board Member -
Private Equity Investor 01/04/2005
Sp2 Asset Management Ltd. Director/Board Member -
Tous les postes actifs de Stephen Parker

Anciens postes connus de Stephen Parker

SociétésPosteFin
ARGENT BIOPHARMA LIMITED Chairman 01/12/2023
░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Stephen Parker

Formation de Stephen Parker

University of Oxford Doctorate Degree
University of East Anglia Undergraduate Degree
Bayes Business School Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Stephen Parker

Relations

82

Relations au 1er degré

32

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées5
SAREUM HOLDINGS PLC

Miscellaneous

ARGENT BIOPHARMA LIMITED

Health Technology

SILENCE THERAPEUTICS PLC

Commercial Services

PHYSIOMICS PLC

Commercial Services

BIODEXA PHARMACEUTICALS PLC

Health Technology

Entreprise privées24

Commercial Services

Finance

Finance

Commercial Services

Warburg Group Plc

Finance

Finance

Health Technology

Finance

Finance

Finance

UK Stem Cell Foundation

Miscellaneous

Health Technology

Finance

Health Technology

Retail Trade

Health Technology

Health Technology

Sp2 Consulting Ltd.

Health Technology

Health Technology

Eternans Ltd.

Health Technology

Sp2 Asset Management Ltd.

Xenova Ltd.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Stephen Parker